Biotech ETF Hits Key $300 Level for the First Time in 9 Months

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 23 September, 2016 by The TZ Newswire Staff

Biotech ETF Hits Key $300 Level for the First Time in 9 Months

The world’s largest biotech etf, the iShares NASDAQ Biotechnology Index (NASDAQ:IBB), closed above the $300 level yesterday for the first time since January.

See also
- Next Article Key Words: Gary Johnson bites tongue in bid to demonstrate how debate slot would aid his presidential bid
- Previous Article T-Mobile to End Free iPhone Upgrades Sunday (TMUS)
Editorial Calender

September 2016

M T W T F S S

1 2 3 4

5 6 7 8 9 10 11

12 13 14 15 16 17 18

19 20 21 22 23 24 25

26 27 28 29 30

« Aug Oct »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 23 September, 2016 by The TZ Newswire Staff

Biotech ETF Hits Key $300 Level for the First Time in 9 Months

See also

Editorial Calender

Recent Tags